Johnson Amy R, Banks Matthew L, Blough Bruce E, Lile Joshua A, Nicholson Katherine L, Negus S Stevens
Department of Pharmacology and Toxicology, Virginia Commonwealth University Richmond, VA, United States.
Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, NC, United States.
Drug Alcohol Depend. 2016 Aug 1;165:103-10. doi: 10.1016/j.drugalcdep.2016.05.021. Epub 2016 May 28.
Homologous cocaine self-administration procedures in laboratory animals and humans may facilitate translational research for medications development to treat cocaine dependence. This study, therefore, sought to establish choice between cocaine and an alternative reinforcer in rhesus monkeys responding under a procedure back-translated from previous human studies and homologous to a human laboratory procedure described in a companion paper.
Four rhesus monkeys with chronic indwelling intravenous catheters had access to cocaine injections (0, 0.043, 0.14, or 0.43mg/kg/injection) and food (0, 1, 3, or 10 1g banana-flavored food pellets). During daily 5h sessions, a single cocaine dose and a single food-reinforcer magnitude were available in 10 30-min trials. During the initial "sample" trial, the available cocaine and food reinforcer were delivered non-contingently. During each of the subsequent nine "choice" trials, responding could produce either the cocaine or food reinforcer under an independent concurrent progressive-ratio schedule.
Preference was governed by the cocaine dose and food-reinforcer magnitude, and increasing cocaine doses produced dose-dependent increases in cocaine choice at all food-reinforcer magnitudes. Effects of the candidate medication lisdexamfetamine (0.32-3.2mg/kg/day) were then examined on choice between 0.14mg/kg/injection cocaine and 10 pellets. Under baseline conditions, this reinforcer pair maintained an average of approximately 6 cocaine and 3 food choices. Lisdexamfetamine dose-dependently decreased cocaine choice in all monkeys, but food choice was not significantly altered.
These results support utility of this procedure in rhesus monkeys as one component of a platform for translational research on medications development to treat cocaine use disorder.
实验室动物和人类的同源可卡因自我给药程序可能有助于开展用于治疗可卡因依赖的药物开发的转化研究。因此,本研究试图在恒河猴中建立可卡因与另一种强化物之间的选择,该程序是根据先前人类研究反向翻译而来,并且与一篇配套论文中描述的人类实验室程序同源。
四只植入慢性静脉导管的恒河猴可以获得可卡因注射(0、0.043、0.14或0.43毫克/千克/注射)和食物(0、1、3或10颗香蕉味食物颗粒)。在每天5小时的实验时段内,在10次30分钟的试验中提供单一剂量的可卡因和单一强度的食物强化物。在最初的“样本”试验中,提供的可卡因和食物强化物是非条件给予的。在随后的9次“选择”试验中的每次试验中,根据独立的并发累进比率程序,反应可以产生可卡因或食物强化物。
偏好受可卡因剂量和食物强化物强度的支配,并且在所有食物强化物强度下,增加可卡因剂量会导致可卡因选择呈剂量依赖性增加。然后研究了候选药物赖氨酸右旋苯丙胺(0.32 - 3.2毫克/千克/天)对0.14毫克/千克/注射可卡因和10颗食物颗粒之间选择的影响。在基线条件下,这对强化物平均维持约6次可卡因选择和3次食物选择。赖氨酸右旋苯丙胺在所有猴子中均剂量依赖性地减少了可卡因选择,但食物选择没有显著改变。
这些结果支持该程序在恒河猴中的实用性,作为治疗可卡因使用障碍的药物开发转化研究平台的一个组成部分。